MARC Record from marc_columbia

LEADER: 17576cam a22004454a 4500
001 6359656
005 20221122025239.0
008 070912t20082008pauab b 001 0 eng
010 $a 2007037803
016 7 $a101316369$2DNLM
020 $a9780781782050
020 $a0781782058
029 1 $aNLM$b101316369
035 $a(OCoLC)ocn173182594
035 $a(OCoLC)173182594
035 $a(NNC)6359656
035 $a6359656
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dC#P$dOrLoB-B
042 $apcc
050 00 $aRC685.H8$bH923 2008
060 10 $aWG 340$bH99654 2008
082 00 $a616.1/32$222
245 00 $aHypertension primer :$b[the essentials of high blood pressure : basic science, population science, and clinical management] /$ceditors, Joseph L. Izzo Jr., Domenic A. Sica, Henry R. Black.
250 $a4th ed.
260 $aPhiladelphia, PA :$bLippincott Williams & Wilkins,$c[2008], ©2008.
300 $axxix, 610 pages :$billustrations, map ;$c28 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
505 00 $gSect. I.$tIon Transport and Signal Transduction -- $gCh. 1.$tSignal Transduction: Receptors /$rGreti Aguilera -- $gCh. 2.$tGuanine Nucleotide Binding Proteins /$rJames C. Garrison -- $gCh. 3.$tCyclic Nucleotides and Their Regulation /$rStanko S. Stojilkovic -- $gCh. 4.$tSignal Transduction: Inositol Phospholipids and Inositol Phosphates /$rTamas Balla -- $gCh. 5.$tProtein Phosphorylation /$rGeorge W. Booz and Kenneth M. Baker -- $gCh. 6.$tIntracellular pH and Cell Volume /$rBradford C. Berk -- $gCh. 7.$tCellular Potassium Transport /$rJason X.-J. Yuan and Mordecai P. Blaustein -- $gCh. 8.$tCalcium Transport and Calmodulin /$rDavid J. Triggle -- $gCh. 9.$tReactive Oxygen Species and Mediators of Oxidative Stress /$rRhian M. Touyz -- $gCh. 10.$tVascular Smooth Muscle Contraction and Relaxation /$rRita C. Tostes, Romulo Leite and R. Clinton Webb -- $gSect. II.$tVasoactive Substances -- $gCh. 11.$tCatecholamine Synthesis, Release, Reuptake, and Metabolism /$rDavid S. Goldstein and Graeme Eisenhofer -- $gCh. 12.$tAdrenergic and Dopaminergic Receptors and Actions /$rKathleen H. Berecek and Robert M. Carey -- $gCh. 13.$tProrenin and Renin /$rWilliam H. Beierwaltes -- $gCh. 14.$tAngiotensinogen /$rMorton P. Printz -- $gCh. 15.$tAngiotensin I - Converting Enzyme and Neprilysin (Neutral Endopeptidase) /$rRandal A. Skidgel and Ervin G. Erdos -- $gCh. 16.$tAngiotensin Formation and Degradation /$rCarlos M. Ferrario and Mark C. Chappell -- $gCh. 17.$tAngiotensins: Actions and Receptors /$rTheodore L. Goodfriend -- $gCh. 18.$tTissue Renin-Angiotensin Systems /$rNancy J. Brown -- $gCh. 19.$tAdrenal Steroid Synthesis and Regulation /$rCelso E. Gomez-Sanchez -- $gCh. 20.$tMineralocorticoid Receptors /$rTae-Yon Chun and J. Howard Pratt -- $gCh. 21.$tEndothelin /$rErnesto L. Schiffrin -- $gCh. 22.$tVasopressin and Neuropeptide Y /$rAllen W. Cowley, Jr. and Mieczyslaw Michalkiewicz -- $gCh. 23.$tCalcitonin Gene-Related Peptides and Adrenomedullin-Derived Peptides /$rDonald J. DiPette and Scott Supowit -- $gCh. 24.$tAcetylcholine, [gamma]-Aminobutyric Acid, Serotonin, Adenosine, and Endogenous Ouabain /$rJohn M. Hamlyn -- $gCh. 25.$tVascular and Renal Nitric Oxide /$rLeopoldo Raij -- $gCh. 26.$tKinins /$rOscar A. Carretero and Nour-Eddine Rhaleb -- $gCh. 27.$tEndogenous Natriuretic Peptides /$rWillis K. Samson and Domenic A. Sica -- $gCh. 28.$tVasoactive Growth Factors /$rCarrie A. Northcott and Stephanie W. Watts -- $gCh. 29.$tPlasminogen Activation and the Renin-Angiotensin System /$rDouglas E. Vaughan -- $gCh. 30.$tProstaglandins and P450 Metabolites /$rAlberto Nasjletti and John C. McGiff -- $gCh. 31.$tLipoxygenase Products /$rMichael D. Williams and Jerry L. Nadler -- $gCh. 32.$tPeroxisome Proliferator - Activated Receptors /$rSanjeev A. Francis and Jorge Plutzky -- $gCh. 33.$tEndocannabinoids /$rGeorge Kunos and Pal Pacher -- $gCh. 34.$tActive Products of Adipocytes /$rNathaniel Winer -- $gCh. 35.$tLeptin /$rWilliam G. Haynes -- $gCh. 36.$tAdiponectin /$rWilla A. Hsueh and Rajendra K. Tangirala -- $gSect. III.$tVasoregulatory Systems -- $gCh. 37.$tCentral Nervous System in Arterial Pressure Regulation /$rJ. Michael Wyss -- $gCh. 38.$tArterial Baroreflexes /$rMark W. Chapleau -- $gCh. 39.$tCardiopulmonary Baroreflexes /$rMark E. Dunlap -- $gCh. 40.$tRenal Sympathetic Nerves and Extracellular Fluid Volume Regulation /$rEdward J. Johns -- $gCh. 41.$tSystemic Hemodynamics and Regional Blood Flow Regulation /$rThomas G. Coleman and John E. Hall -- $gCh. 42.$tLocal Autoregulation of Tissue Blood Flow /$rRobert L. Hester and John E. Hall -- $gCh. 43.$tRespiration and Blood Pressure /$rGianfranco Parati, Joseph L. Izzo, Jr. and Benjamin Gavish -- $gCh. 44.$tPulsatile Blood Flow and Shear Stress /$rMichel E. Safar and Gary F. Mitchell -- $gSect. IV.$tPathophysiology of Primary and Secondary Hypertension -- $gCh. 45.$tAging, Arterial Function, and Systolic Hypertension /$rStanley S. Franklin and Gary F. Mitchell -- $gCh. 46.$tObesity-Related Hypertension /$rEfrain Reisin -- $gCh. 47.$tInsulin Actions and Insulin Resistance /$rAdam Whaley-Connell, Samy I. McFarlane and James R. Sowers -- $gCh. 48.$tPolycystic Ovary Syndrome /$rCaren G. Solomon and Ellen W. Seely -- $gCh. 49.$tSalt Sensitivity /$rFernando Elijovich and Cheryl L. Laffer -- $gCh. 50.$tPathophysiology of Renal Parenchymal Hypertension /$rVito M. Campese and Jeanie Park -- $gCh. 51.$tPathophysiology of Renovascular Hypertension /$rL. Gabriel Navar and David W. Ploth -- $gCh. 52.$tCoarctation of the Aorta /$rAlbert P. Rocchini -- $gCh. 53.$tHypertension Caused by Thyroid and Parathyroid Abnormalities, Acromegaly, and Androgens /$rYoram Shenker -- $gCh. 54.$tPathophysiology of Preeclampsia /$rEllen W. Seely and Marshall D. Lindheimer -- $gCh. 55.$tPathophysiology of Sleep Apnea /$rBarbara J. Morgan -- $gCh. 56.$tBlood Pressure Variability and Reactivity /$rJoseph L. Izzo, Jr. -- $gCh. 57.$tExperimental Models of Hypertension /$rRalph E. Watson and Donald J. DiPette -- $gSect. V.$tMechanisms of Target Organ Damage -- $gCh. 58.$tAging, Hypertension, and the Heart /$rEdward G. Lakatta and Samer S. Najjar -- $gCh. 59.$tPathogenesis of Hypertensive Left Ventricular Hypertrophy and Diastolic Dysfunction /$rEdward D. Frohlich -- $gCh. 60.$tPathogenesis of Chronic Heart Failure /$rThierry H. Le Jemtel and Pierre V. Ennezat -- $gCh. 61.$tMechanisms of Vascular Remodeling /$rGary L. Baumbach -- $gCh. 62.$tMicrovascular Regulation and Dysregulation /$rAndrew S. Greene -- $gCh. 63.$tOxidative Stress and Hypertension /$rDavid G. Harrison and Kathy K. Griendling -- $gCh. 64.$tEndothelial Function and Cardiovascular Disease /$rJulian P. J. Halcox and Arshed A. Quyyumi -- $gCh. 65.$tAtherogenesis and Coronary Artery Disease /$rThomas D. Giles -- $gCh. 66.$tPathogenesis of Stroke /$rJ. David Spence -- $gCh. 67.$tPathogenesis of Acute Hypertensive Encephalopathy /$rDonald D. Heistad, Frank M. Faraci and William T. Talman -- $gCh. 68.$tPathogenesis of Mild Cognitive Impairment and Dementia /$rLinda A. Hershey -- $gCh. 69.$tPathogenesis of Nephrosclerosis and Chronic Kidney Disease /$rSharon Anderson -- $gCh. 70.$tThe Eye in Hypertension /$rRobert N. Frank -- $gSect. VI.$tBasic Genetics -- $gCh. 71.$tGenetics of Hypertension /$rAlan B. Weder -- $gCh. 72.$tMonogenic Determinants of Blood Pressure /$rRobert G. Dluhy -- $gCh. 73.$tHeritability of Hypertension and Target Organ Damage /$rDonna K. Arnett -- $gSect. I.$tCardiovascular Risk in Populations and Individuals -- $gCh. 74.$tGeographic Patterns of Hypertension: A Global Perspective /$rRichard S. Cooper and Bamidele Tayo -- $gCh. 75.$tGeographic Patterns of Hypertension in the United States /$rGeorge A. Mensah -- $gCh. 76.$tCardiovascular Risk Factors and Hypertension /$rWilliam B. Kannel and Peter W. F. Wilson -- $gCh. 77.$tIschemic Heart Disease Risk /$rDonald M. Lloyd-Jones -- $gCh. 78.$tLeft Ventricular Hypertrophy and Cardiovascular Disease Risk /$rDaniel Levy -- $gCh. 79.$tCerebrovascular Risk /$rPhilip A. Wolf -- $gCh. 80.$tRenal Risk /$rLuis M. Ruilope and Joseph L. Izzo, Jr. -- $gCh. 81.$tPeripheral Arterial Disease and Hypertension /$rEmile R. Mohler III and Michael H. Criqui -- $gSect. II.$tHypertension in Special Populations -- $gCh. 82.$tGender and Blood Pressure /$rEduardo Pimenta and Suzanne Oparil -- $gCh. 83.$tBlood Pressure in Children /$rBruce Z. Morgenstern and Alan R. Sinaiko -- $gCh. 84.$tEthnicity and Socioeconomic Status in Hypertension /$rJohn M. Flack, Samar A. Nasser and Shannon M. O'Connor -- $gCh. 85.$tHypertension in Blacks /$rKeith C. Ferdinand -- $gCh. 86.$tHypertension Among Hispanics in the United States /$rCarlos J. Crespo and Mario R. Garcia-Palmieri -- $gCh. 87.$tHypertension in South Asians /$rPrakash C. Deedwania and Rajeev Gupta -- $gCh. 88.$tHypertension in East Asians and Native Hawaiians /$rKhiet C. Hoang and Nathan D. Wong -- $gSect. III.$tLifestyle Factors and Blood Pressure -- $gCh. 89.$tStress, White Coat Hypertension, and Masked Hypertension /$rThomas G. Pickering -- $gCh. 90.$tObesity, Body Fat Distribution, and Insulin Resistance: Clinical Relevance /$rSteven M. Haffner and Henry R. Black --
500 $a"From the Council on High Blood Pressure, American Heart Association."
500 $aSubtitle from cover.
504 $aIncludes bibliographical references and index.
505 80 $gCh. 91.$tPhysical Activity and Blood Pressure /$rDenise G. Simons-Morton -- $gCh. 92.$tDietary Patterns and Blood Pressure /$rFrank M. Sacks -- $gCh. 93.$tSalt and Blood Pressure /$rMyron H. Weinberger -- $gCh. 94.$tPotassium and Blood Pressure /$rPaul K. Whelton -- $gCh. 95.$tBlood Pressure Effects of Dietary Calcium Magnesium Intake and Heavy Metal Exposure /$rLawrence J. Appel and Ana Navas-Acien -- $gCh. 96.$tAlcohol Use and Blood Pressure /$rWilliam C. Cushman -- $gSect. IV.$tPrevention and Control -- $gCh. 97.$tTrends in Blood Pressure Control and Mortality /$rThomas J. Thorn and Edward J. Roccella -- $gCh. 98.$tPrevention of Hypertension /$rJeffrey A. Cutler and Jeremiah Stamler -- $gCh. 99.$tCommunity-Based Management Programs /$rDaniel T. Lackland and Brent M. Egan -- $gCh. 100.$tAntihypertensive Treatment Trials: Outcomes /$rWilliam J. Elliott -- $gCh. 101.$tAntihypertensive Treatment Trials: Quality of Life /$rRichard H. Grimm, Jr. and Carrie L. Schleis -- $gCh. 102.$tEconomic Considerations in Hypertension Management /$rWilliam J. Elliott -- $gSect. I.$tGeneral Diagnostic Aspects -- $gCh. 103.$tBlood Pressure Measurement /$rCarlene M. Grim and Clarence E. Grim -- $gCh. 104.$tAmbulatory and Home Blood Pressure Monitoring /$rWilliam B. White -- $gCh. 105.$tInitial Workup of Adults with Hypertension /$rJoseph L. Izzo, Jr., Domenic A. Sica and Henry R. Black -- $gCh. 106.$tResistant Hypertension /$rNorman M. Kaplan and Domenic A. Sica -- $gCh. 107.$tDefining the Syndrome of Hypertension /$rJoseph L. Izzo, Jr., Thomas D. Giles and Barry J. Materson -- $gSect. II.$tEvaluation of Target Organs -- $gCh. 108.$tEvaluation of Electrolyte Abnormalites in Hypertension /$rJohn W. Graves -- $gCh. 109.$tBasic Cardiac Evaluation: Physical Examination, Electrocardiogram, Chest Radiograph, and Stress Testing /$rClarence Shub and Andrew J. Luisi, Jr. -- $gCh. 110.$tCardiac Imaging /$rClarence Shub -- $gCh. 111.$tEvaluation of Heart Failure /$rKirkwood F. Adams, Jr. -- $gCh. 112.$tEvaluation of Arterial Stiffness and Central Systolic Pressure /$rJoseph L. Izzo, Jr. -- $gCh. 113.$tEvaluation of the Peripheral Circulation /$rJeffrey W. Olin -- $gCh. 114.$tNeurologic Evaluation in Hypertension /$rStephen J. Phillips -- $gCh. 115.$tEvaluation of Chronic Kidney Disease /$rMichael A. Moore and Domenic A. Sica -- $gCh. 116.$tEvaluation of Renovascular Disease /$rStephen C. Textor -- $gCh. 117.$tEvaluation of Aortocarotid Baroreflexes /$rAddison A. Taylor and Naveed Iqbal -- $gSect. III.$tPrinciples of Management -- $gCh. 118.$tEvolution of American, European, and British Hypertension Guidelines /$rHenry R. Black, Bryan Williams and Joseph L. Izzo, Jr. -- $gCh. 119.$tOffice Management of Hypertension /$rJoseph L. Izzo, Jr., Henry R. Black and Domenic A. Sica -- $gCh. 120.$tLifestyle Modifications /$rTheodore A. Kotchen and Jane Morley Kotchen -- $gCh. 121.$tExercise Therapy /$rDenise G. Simons-Morton -- $gCh. 122.$tPatient Education /$rDaniel W. Jones -- $gCh. 123.$tAdherence to Antihypertensive Therapy /$rCheryl R. Dennison and Nancy Houston Miller -- $gCh. 124.$tBarriers to Blood Pressure Control /$rDavid J. Hyman and Valory N. Pavlik -- $gCh. 125.$tHypertension Consultations /$rLawrence R. Krakoff -- $gCh. 126.$tNonphysician Providers and the Management of Hypertension /$rBarry L. Carter -- $gCh. 127.$tHypertension Recordkeeping and Electronic Management Systems /$rMary K. Goldstein and Brian B. Hoffman -- $gSect. IV.$tAntihypertensive Drugs -- $gCh. 128.$tAntihypertensive Drugs: Pharmacologic Principles and Dosing Effects /$rJoseph L. Izzo, Jr. and Domenic A. Sica -- $gCh. 129.$tDrug Combinations /$rAlan H. Gradman -- $gCh. 130.$tThiazide and Loop Diuretics /$rDomenic A. Sica -- $gCh. 131.$tAldosterone Blockers and Potassium-Sparing Diuretics /$rMurray Epstein -- $gCh. 132.$t[beta]-Adrenergic Blockers /$rWilliam H. Frishman and Domenic A. Sica -- $gCh. 133.$t[alpha]-Adrenoceptor Antagonists /$rJames L. Pool -- $gCh. 134.$tCentral and Peripheral Sympatholytics /$rBarry J. Materson -- $gCh. 135.$tRenin Inhibitors /$rNorman K. Hollenberg -- $gCh. 136.$tAngiotensin-Converting Enzyme Inhibitors /$rDomenic A. Sica -- $gCh. 137.$tAngiotensin Receptor Blockers /$rMichael A. Weber -- $gCh. 138.$tCalcium Antagonists /$rMatthew R. Weir -- $gCh. 139.$tDirect Arterial Dilators /$rC. Venkata S. Ram and Andrew Fenves -- $gCh. 140.$tNitrates, Dopamine Agonists, Potassium Channel Openers, and Serotonin-Related Agents /$rAlexander M. M. Shepherd -- $gCh. 141.$tVasopressin Inhibitors /$rHaralambos Gavras and Irene Gavras -- $gCh. 142.$tEndothelin Antagonists /$rWilliam J. Elliott -- $gCh. 143.$tAntihypertensive Effects of Nonantihypertensive Drugs /$rRoss D. Feldman -- $gCh. 144.$tBlood Pressure-Raising Effects of Anti-inflammatory Drugs, Angiogenesis Inhibitors, and Cholesterol-Ester-Transfer Protein Inhibitors /$rRaymond R. Townsend -- $gSect. V.$tManaging Hypertension in Special Populations -- $gCh. 145.$tTreatment of Prehypertension /$rHenry R. Black and Joseph L. Izzo, Jr. -- $gCh. 146.$tTreatment of the Elderly Hypertensive: Systolic Hypertension /$rJan N. Basile -- $gCh. 147.$tTreatment of Hypertensive Urgencies and Emergencies /$rDonald G. Vidt -- $gCh. 148.$tTreatment of Hypertension in Minorities /$rMahboob Rahman and Jackson T. Wright, Jr. -- $gCh. 149.$tTreatment of Hypertensive Patients with Ischemic Heart Disease /$rClive Rosendorff -- $gCh. 150.$tManagement of Hypertensive Patients with Left Ventricular Hypertrophy and Diastolic Dysfunction /$rRichard B. Devereux -- $gCh. 151.$tTreatment of Hypertensive Patients with Left Ventricular Systolic Dysfunction /$rJohn B. Kostis -- $gCh. 152.$tTreatment of Hypertensive Patients with Peripheral Arterial Disease /$rJeffrey W. Olin -- $gCh. 153.$tTreatment of Hypertensive Patients with Cerebrovascular Disease /$rRobert D. Brown, Jr. -- $gCh. 154.$tTreatment of Orthostatic Disorders and Baroreflex Failure /$rDavid Robertson -- $gCh. 155.$tSexual Dysfunction and Hypertension /$rL. Michael Prisant -- $gCh. 156.$tTreatment of Hypertension with Chronic Renal Insufficiency or Albuminuria /$rAtul R. Chugh and George L. Bakris -- $gCh. 157.$tTreatment of the Obese Hypertensive Patient /$rXavier Pi-Sunyer -- $gCh. 158.$tTreatment of Hypertensive Patients with Abnormal Blood Glucose /$rGuido Lastra, Samy I. McFarlane and James R. Sowers -- $gCh. 159.$tDyslipidemia Management in Hypertensives /$rPeter P. Toth -- $gCh. 160.$tTreatment of Pregnant Hypertensive Patients /$rSandra J. Taler -- $gCh. 161.$tTreatment of Hypertensive Children and Adolescents /$rBonita Falkner -- $gCh. 162.$tManagement of Hypertension and Psychiatric Disorders /$rSteven L. Dubovsky -- $gCh. 163.$tHypertension in Athletes /$rJohn J. Leddy -- $gCh. 164.$tPerioperative Management of Hypertension /$rJohn D. Bisognano and Michael W. Fong -- $gSect. VI.$tManagement of Secondary Hypertension -- $gCh. 165.$tManagement of Sleep Apnea /$rVirend K. Somers, Sean M. Caples and Do -- $gCh. 166.$tManagement of Drug-Induced and Iatrogenic Hypertension /$rEhud Grossman, Franz H. Messerli and Domenic A. Sica -- $gCh. 167.$tManagement of Hyperaldosteronism and Hypercortisolism /$rDavid A. Calhoun -- $gCh. 168.$tTreatment of Renovascular Hypertension /$rJoseph V. Nally, Jr. -- $gCh. 169.$tManagement of Pheochromocytoma /$rWilliam F. Young, Jr. and Sheldon G. Sheps -- $gCh. 170.$tManagement of Thyroid and Parathyroid Disorders /$rWilliam F. Young, Jr. -- $gCh. 171.$tManagement of Post-transplant Hypertension /$rVincent J. Canzanello -- $tConflict of Interest Table.
650 0 $aHypertension.$0http://id.loc.gov/authorities/subjects/sh85063723
650 12 $aHypertension.$0https://id.nlm.nih.gov/mesh/D006973
700 1 $aIzzo, Joseph L.$0http://id.loc.gov/authorities/names/n93804423
700 1 $aSica, Domenic A.$0http://id.loc.gov/authorities/names/n84102194
700 1 $aBlack, Henry R.$q(Henry Richard),$d1942-$0http://id.loc.gov/authorities/names/n79010997
710 2 $aCouncil for High Blood Pressure Research (American Heart Association)$0http://id.loc.gov/authorities/names/n84003128
852 00 $boff,hsl$hRC685.H8$iH923 2008